BioCentury
ARTICLE | Company News

CBMG gets NSCLC vaccine, plans combo trial with Opdivo

June 10, 2015 1:51 AM UTC

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) said it acquired cancer vaccine CD40LGVAX from Blackbird Bio Finance, which held rights to the vaccine discovered by University of South Florida College of Medicine professor Scott Antonia. CD40LGVAX consists of irradiated allogeneic lung adenocarcinoma cells combined with a cell line transfected with hCD40L and hGM-CSF.

CBMG will pay $2.5 million in cash and $1.8 million in stock up front plus more than $25 million in potential milestones and royalties. ...